Noberasco C - Search Results

1

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

Zilembo N, Noberasco C, Bajetta E, Martinetti A, Mariani L, Orefice S, Buzzoni R, Di Bartolomeo M, Di Leo A, Laffranchi A, et al. Zilembo N, et al. Among authors: noberasco c. Br J Cancer. 1995 Oct;72(4):1007-12. doi: 10.1038/bjc.1995.451. Br J Cancer. 1995. PMID: 7547212 Free PMC article.

2

Second-generation aromatase inhibitors.

Bajetta E, Zilembo N, Noberasco C. Bajetta E, et al. Among authors: noberasco c. Tumori. 1995 Mar-Apr;81(2):77-80. doi: 10.1177/030089169508100201. Tumori. 1995. PMID: 7778222 Clinical Trial. No abstract available.

3

Formestane: an effective first-line endocrine treatment for advanced breast cancer.

Zilembo N, Bajetta E, Noberasco C, Buzzoni R, Vicario G, Bono A, Laffranchi A, Biasi G, Dolci S, Bichisao E. Zilembo N, et al. Among authors: noberasco c. J Cancer Res Clin Oncol. 1995;121(6):378-82. doi: 10.1007/BF01225692. J Cancer Res Clin Oncol. 1995. PMID: 7797604

4

Formestane: effective therapy in postmenopausal women with advanced breast cancer.

Bajetta E, Zilembo N, Buzzoni R, Noberasco C, Martinetti A, Ferrari L, Bartoli C, Sacchini V, Attili A, Lepera P. Bajetta E, et al. Among authors: noberasco c. Ann Oncol. 1994;5 Suppl 7:S15-7. Ann Oncol. 1994. PMID: 7873456 Clinical Trial.

5

Formestane as treatment of advanced breast cancer in elderly women.

Zilembo N, Buzzoni R, Celio L, Noberasco C, Ferrari L, Laffranchi A, Vicario G, Dolci S, Bajetta E. Zilembo N, et al. Among authors: noberasco c. Tumori. 1994 Dec 31;80(6):433-7. doi: 10.1177/030089169408000605. Tumori. 1994. PMID: 7900232 Clinical Trial.

6

Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.

Ferrari L, Zilembo N, Bajetta E, Buzzoni R, Noberasco C, Martinetti A, Celio L, Galante E, Orefice S, Cerrotta AM. Ferrari L, et al. Among authors: noberasco c. Breast Cancer Res Treat. 1994;30(2):127-32. doi: 10.1007/BF00666055. Breast Cancer Res Treat. 1994. PMID: 7949210 Clinical Trial.

7

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.

Bajetta E, Zilembo N, Buzzoni R, Noberasco C, Di Leo A, Bartoli C, Merson M, Sacchini V, Moglia D, Celio L, et al. Bajetta E, et al. Among authors: noberasco c. Br J Cancer. 1994 Jul;70(1):145-50. doi: 10.1038/bjc.1994.265. Br J Cancer. 1994. PMID: 8018527 Free PMC article. Clinical Trial.

8

Hormone therapy in advanced breast carcinoma: present and future trends.

Bajetta E, Zilembo N, Di Leo A, Buzzoni R, Zampino MG, Biganzoli L, Noberasco C. Bajetta E, et al. Among authors: noberasco c. Cancer Treat Rev. 1994 Jul;20(3):241-58. doi: 10.1016/0305-7372(94)90002-7. Cancer Treat Rev. 1994. PMID: 8020005 Review. No abstract available.

9

Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.

Bajetta E, Zilembo N, Buzzoni R, Noberasco C, Celio L, Bichisao E. Bajetta E, et al. Among authors: noberasco c. Cancer Treat Rev. 1993 Apr;19 Suppl B:31-6. doi: 10.1016/0305-7372(93)90005-c. Cancer Treat Rev. 1993. PMID: 8481932

10

The minimal effective exemestane dose for endocrine activity in advanced breast cancer.

Bajetta E, Zilembo N, Noberasco C, Martinetti A, Mariani L, Ferrari L, Buzzoni R, Greco M, Bartoli C, Spagnoli I, Danesini GM, Artale S, Paolini J. Bajetta E, et al. Among authors: noberasco c. Eur J Cancer. 1997 Apr;33(4):587-91. doi: 10.1016/s0959-8049(96)00494-7. Eur J Cancer. 1997. PMID: 9274439 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page